MedTrace Logo

Efficacy of Anthocyanin Mouthrinse for Oral Anti-inflammation From Orthodontic Treatment

NCT02536781 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2017-08-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the oral inflammatory reduction effect caused from orthodontic treatment of anthocyanin and placebo mouthrinse.

Conditions

  • Inflammation of Mouth
  • Acute Mucous Inflammation

Interventions

DRUG

Anthocyanin

Anti-inflammation gel

DRUG

Placebo

Blank gel

Sponsors & Collaborators

  • Khon Kaen University

    lead OTHER

Principal Investigators

  • Sucharat Limsitthichaikoon · Khon Kaen University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • Thailand

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02536781 on ClinicalTrials.gov